Vote Scores

Home / Companies / Sichuan Kelun Pharmaceutical Co., Ltd. / 15 May 2024

Meeting · year to 30 June 202440 filers reporting

Sichuan Kelun Pharmaceutical Co., Ltd.: meeting of 15 May 2024

Votes reported on Form N-PX, item by item

40 Form N-PX filers reported votes at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting of 15 May 2024. Their records fall into 9 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

9 nominees; 92.3% of reported votes for; 20 filers withheld from or voted against at least one nominee.

604 vote records from 40 filers. 0 of the 40 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management40 filers
2

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

82 vote records from 40 filers. 1 of the 40 filers that marked the item either way voted against management.

97.5% for0.0% against2.5% other2.5% against management40 filers97.7% for1.0% against1.3% other2.3% against management11,774,440 reported shares
3

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

61 vote records from 35 filers. 30 of the 35 filers that marked the item either way voted against management.

14.3% for85.7% against85.7% against management35 filers31.0% for69.0% against69.0% against management10,775,808 reported shares, counted once per item in this group
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

340 vote records from 40 filers. 0 of the 40 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management40 filers66.2% for33.8% against33.8% against management57,173,940 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

132 vote records from 40 filers. 0 of the 40 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management40 filers100.0% for0.0% against0.0% against management22,493,016 reported shares, counted once per item in this group
6

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

293 vote records from 40 filers. 0 of the 40 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management40 filers100.0% for0.0% against0.0% against management54,705,976 reported shares, counted once per item in this group
7

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

56 vote records from 6 filers. 0 of the 6 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management6 filers100.0% for0.0% against0.0% against management1,055,864 reported shares, counted once per item in this group
8

AUDIT-RELATEDSecurity holder

Shareholder proposal: AUDIT-RELATED (A)

54 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers100.0% for0.0% against0.0% against management10,537,942 reported shares
9

AUDIT-RELATEDSecurity holder

Shareholder proposal: AUDIT-RELATED (B)

54 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers100.0% for0.0% against0.0% against management10,537,942 reported shares

How the largest families voted

Family1. Directors2. Auditor8. Proposal9. Proposal
VanguardForForForFor
BlackRock and iSharesForForForFor
FidelityForForForFor
DimensionalForForForFor
State Street and SPDRForForForFor
Franklin TempletonForForForFor
Charles SchwabForForNo reportNo report
Nuveen and TIAAForForForFor
John Hancock and ManulifeForForNo reportNo report
Morgan Stanley, Eaton Vance and CalvertForForForFor
J.P. MorganForForNo reportNo report
Goldman SachsForForForFor
WisdomTreeForForForFor
PGIM and PrudentialForForNo reportNo report
Jackson National fundsForForNo reportNo report
Northern Trust and FlexSharesForForForFor
SEIForForNo reportNo report
Lincoln FinancialForForForFor
VoyaForForForFor
Russell InvestmentsForForNo reportNo report
NationwideForForForFor
BNY MellonForForForFor
Pacific Life fundsForForForFor
AllianceBernsteinForAbstain or withhold *ForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting?

40 Form N-PX filers reported votes at the meeting of 15 May 2024. 2 proposals from security holders could be told apart in the filings. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sichuan Kelun Pharmaceutical Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Sichuan Kelun Pharmaceutical Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sichuan Kelun Pharmaceutical Co., Ltd. with a meeting date within three days of 15 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.